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Β-Thalassaemia is a rare hereditary disease caused by partial or complete deficiency of β-haemoglobin chain synthesis. There is a lot 
of literature regarding anaesthetic management in other haemoglobinopathies (i.e. sickle cell disease), especially in the paediatric 
population, but there is scarce information regarding β-thalassaemia major in adults. With current medical management, 
β-thalassaemia major patients survive to adulthood and may present for a variety of surgical procedures, even unrelated to their 
disease process. It is important for the anaesthetist to be familiar with the pathophysiology of β-thalassaemia major and how 
the disease itself and its treatment or complications (iron deposition from multiple transfusions) can affect anaesthesia. A case 
of a 51-year-old woman with severe β-thalassaemia undergoing laparoscopic cholecystectomy is presented. The anaesthetic 
management and systematic review of the perioperative concerns in severe β-thalassaemia are discussed.
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Case report
A 51-year-old woman with β-thalassaemia, of American Society of 
Anesthesiologists (ASA) physical status IV, presented for 
laparoscopic cholecystectomy. Her past medical history was 
significant for severe anaemia requiring multiple red blood cell 
transfusions since early childhood (on average two units of 
washed red blood cells every two weeks for a haemoglobin of less 
than 8.5 g/dl). This led to severe iron deposition (haemosiderosis) 
with severe multiple organ insufficiency. She suffered from 
right-sided heart failure with lower extremities oedema and 
ascites. Over the last year, she had had recurrent episodes of 
paroxysmal atrial fibrillation and was on oral anticoagulation and 
digoxin. She was diagnosed with pulmonary hypertension and 
her exercise tolerance was less than 10 uphill steps. She had 
cirrhosis Child–Pugh class B. She had hypothyroidism, primary 
ovarian failure and osteoporosis. Her last transfusion was a few 
days prior to surgery. She had a splenectomy at the age of 11.
Her home medications included digoxin, spironolactone, 
furosemide 80 to 125  mg on alternate days, thyroxine, 
ursodeoxycholic acid, allopurinol, deferiprone (oral chelating agent), 
calcium and warfarin (changed to low molecular weight heparin 
(LMWH) perioperatively).
On physical examination the patient was thin (41  kg). Her 
airway assessment revealed a Mallampati score of II, 4  cm 
mouth opening, 5  cm thyromental distance, short neck and 
tonsillar enlargement. She had frontal and maxillary bossing 
but no significant mandibular enlargement. On auscultation 
she was in a regular rhythm with an S3 sound. Her lower 
extremities were oedematous and ascites was present. She 
had no secondary sexual characteristics (pubic/axillary hair, 
breasts).
Her pertinent laboratory values were (abnormal values are given 
in bold):
Laboratory tests Patient’s values Normal values (SI units)
White cell count (WCC) 16.2 c/mm3 4.9–10.8 c/mm3
Haemoglobin (Hb) 12.1 g/dl 11.8–17.8 g/dl
Haematocrit (Hct) 36.8% 37.7–47.9%
Platelets (PLTs) 415 c/mm3 150–350 c/mm3
Prothrombin time (PT) 11.2 s 11–13.5 s
Sodium (Na) 130 mEq/L 136–150 mEq/L
Potassium (K) 4.9 mEq/l 3.5–5.5 mEq/L
Blood urea nitrogen (BUN) 51.05 mmol/L 8.0–16.4 mmol/L




Total bilirubin (T. Bil) 1.8 mg/dl 0.20–1.2 mg/dl
Direct bilirubin (B. Bil) 0.8 mg/dl 0.0–0.5 mg/dl
Transaminase (AST) 37 IU/L 0–45 IU/L
Transaminase (ALT) 30 IU/L 0–45 IU/L
Alkaline phosphatase 79 IU/L 40–150 IU/L
The electrocardiogram (ECG) showed sinus tachycardia at 98 
beats per minute (bpm). Echocardiography revealed a dilated 
right atrium and right ventricle, decreased right ventricular 
function, mild mitral regurgitation and pulmonary hypertension. 
The left ventricle was not dilated and had good 
function. A chest radiograph showed cardiomegaly and an 
increased cardiothoracic ratio.
On arrival in the operating theatre standard ASA monitors, with 
the addition of an awake arterial line, were placed. The patient’s 
blood pressure was 80/55 mm Hg with sinus rhythm at 80 bpm, 
while arterial haemoglobin oxygen saturation (SpO2) was 97% at 
room air. A smooth intravenous induction was performed with 
etomidate, lidocaine and fentanyl. Paralysis was achieved with 
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rocuronium. Despite the facial deformity, tracheal intubation was 
uneventful. Anaesthesia was maintained with sevoflurane, O2 and 
intermittent fentanyl boluses. Peritoneal insufflation with CO2 was 
performed slowly, with the pressure limit set at 12 mm Hg. Through-
out the operation vital signs were stable and oxygenation was 
followed with serial arterial blood gases (ABGs). The operation 
lasted approximately 40 min. At the conclusion of surgery residual 
paralysis was reversed with sugammadex and the patient was 
extubated after regaining consciousness. A total of 200  ml 0.9% 
normal saline (NS) was administered during the procedure (0.9% 
NS was preferred to other crystalloid solutions for its low potassium 
content). Postoperative pain was controlled with intravenous 
paracetamol. No anaesthetic or surgical complications were 
noted. She was discharged from hospital the following day.
Discussion
B-thalassaemia is a congenital haemolytic disorder caused by partial or 
complete deficiency of β-globin chain synthesis. It primarily affects 
people of Mediterranean origin and to a lesser extent people of 
Chinese, Asian and African descent. It is usually described in its mild 
form, β-thalassaemia intermedia. These patients are anaemic but do not 
require frequent transfusions. They may have hepatosplenomegaly. 
B-thalassaemia major arises from the absence of synthesis of β-globin 
chains (β-0 thal). It is inherited on chromosome 11 and patients are 
homozygous for two mutant alleles.1 Anaesthetic management of 
these patients is dictated by the disease itself, the complications of its 
treatment (iron overload from multiple transfusions) and the use of 
preventive measures (chelating agents).
Anaesthetic considerations
Airway
B-thalassaemia major produces maximum erythropoietin release 
and massive marrow hyperplasia.1 Patients may present with 
frontal bossing and expansion of the maxillofacial area.2 There is a 
possibility of difficult mask ventilation and intubation due to 
facial deformity.3,4 Extramedullary haematopoiesis may also occur 
in the vertebral canal, compressing the spinal cord and causing 
several neurologic symptoms, necessitating caution during neck 
manipulation at laryngoscopy. Abnormal dentition increases the 
intubation difficulty and the possibility of tooth damage during 
intubation attempts.
Cardiovascular
Cardiac insufficiency, secondary to haemosiderosis from chronic 
transfusions, ranging from dyspnoea and peripheral oedema to 
congestive cardiomyopathy and cardiac failure may be present.5 
Major β-thalassaemia patients may present with pulmonary 
hypertension and vascular damage (vasculopathy), secondary to 
disturbed nitric oxide physiology.1 Angina, conduction defects, 
pericarditis, arrhythmias and sudden death are all more likely in 
patients with thalassaemia and iron overload (> 2500 μg/L serum 
ferritin). A hyper-dynamic circulation with a high cardiac output, 
a compensatory mechanism to chronic anaemia, and decreased 
blood oxygen carrying capacity may also be present.
Liver
Chronic anaemia induces ineffective erythropoiesis in extramed-
ullary erythropoietic tissue. Hepatomegaly may be present. 
Haemochromatosis, due to chronic transfusion therapy, can lead 
to liver fibrosis, cirrhosis, hepatic failure and hepatocellular 
carcinoma.5 Liver failure decreases the synthesis of plasma-bind-
ing proteins and causes hypoalbuminaemia.
Haematological
Chronic haemolysis leads to chronic anaemia and hyperbiliru-
binemia.2 Β-thalassaemia patients have splenomegaly and 
usually undergo splenectomy at a young age, so the long term 
post-splenectomy infectious and thromboembolic risks must 
be considered.6 Blood smear shows haemolytic anaemia and 
hypochromia with microcytosis. Regular blood transfusions 
result in a high incidence of RBC alloimmunisation, making 
available compatible blood a potential problem.7 Prior to 
blood transfusion care must be taken to reduce the risk of allo-
immunisation, by matching donors of the same ethnic origin 
and using leukocyte-depleted and/or washed red blood cells. 
Intraoperative blood loss can be managed with cell savage, 
thus avoiding alloimmunisation and further iron overload.1,8 
For patients with a human leukocyte antigen (HLA) identical 
sibling, bone marrow transplantation is a therapeutic option 
for young patients.
Endocrine
Chronic iron overload affects most endocrine organs.9 It affects 
the pancreas, causing pancreatic dysfunction and diabetes 
mellitus; the parathyroids, presenting as hypoparathyroidism and 
hypocalcaemia; and the pituitary, manifesting as hypopituitarism, 
growth failure, hypogonadism and infertility.5,10
Coagulopathy
Haemosiderosis-induced liver failure is associated with coagulopathy, 
thrombocytopenia and bleeding.5
Infectious
There is high incidence of blood-borne infections (hepatitis B, C and 
HIV), especially in older patients from underdeveloped countries. 
They also have a lifetime risk of aplastic crisis from infection with 
parvovirus B infection.
Pharmacokinetics
Β-thalassaemia patients may have increased plasma volume due to 
shunting through expanded bone marrow. Hypoalbuminaemia and 
deceased plasma-binding proteins impair drug binding and metab-
olism and affect drug half-lives. Chelating agents (i.e. deferasirox) 
affect drug-metabolising enzymes (CYP3A4,) influencing drug 
serum values.5,6
Neurological
Mental retardation (secondary to severe anaemia and hypoxia at 




Β-thalassaemia does not affect the accuracy of pulse oximetry. In 
β-thalassaemia foetal haemoglobin is increased and the oxyhaemo-
globin dissociation curve is shifted to the left leading to decreased 
unloading of oxygen to the tissues.
Positioning
Care must be taken with positioning of such patients as they are prone 
to fractures due to accelerated demineralisation and osteopenia. Iron 
deposition at the joints can cause arthritis affecting all joints.
Conclusion
We have presented a case report of a 51-year-old patient with 
β-thalassaemia major undergoing laparoscopic cholecystectomy. 
The patient was born in 1961 in Greece and was one of the first 
patients to be started on chronic hypertransfusion therapy. Never-
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theless, it was not until her twenties that iron chelation therapy was 
introduced. Our patient exhibits an interesting pathophysiology, as 
she survived past childhood due to the initiation of chronic hyper-
transfusion therapy, but suffered almost all of the complications of 
iron overload due to delay in the initiation of chelating therapy in 
the 1960s when she was born.
The anaesthetic management of this severe form of β-thalassaemia 
requires multiple considerations including the airway, cardiovascu-
lar system, liver and coagulation system.11 Anaesthetists should be 
aware of both the pathophysiology of the disease and the potential 
complications of its treatment. Meticulous consideration should be 
paid to each one of the systems involved in order to achieve the 
best possible outcome in these patients.
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